Yeah, all that wondering gives me an uncomfortable feeling. Why is nobody knocking? And why does SPL seem so reluctant to complete any of the DEP Phase 2 trials? As seen in the annual report, SPL keeps recruiting more patients and expanding the scope of the trials, BUT without any explanation. We are left to wonder and speculate...
Ann: Starpharma annual report and full year financial results, page-58
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
